Clinical Trial Update: Impacts of PIO/MET Following Short-term Intensive Insulin Treatment in Newly Diagnosed Type 2 Diabetes [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update evaluating the effects of pioglitazone/metformin following short-term intensive insulin therapy in newly diagnosed Type 2 Diabetes…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• PIOGLITAZONE (Pioglitazone)
• Pioglitazone/metformin (pioglitazone/metformin)
• metformin (metformin)

Snippet

Sponsor: Sun Yat-sen University | Conditions: Type 2 Diabetes Mellitus | Phase 4 | Status: UNKNOWN